Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases)

Purinergic Signalling

Volumn 5, Issue 1, 2009, Pages 91-106

  Baqi, Younis ^a   Weyler, Stefanie ^a   Iqbal, Jamshed ^a   Zimmermann, Herbert ^b   Müller, Christa E ^a  

^a UNIVERSITY OF BONN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Anthraquinone; E NTPDase; Inhibitor; Reactive blue 2; Synthesis

Indexed keywords

EID: 60449095619     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-008-9103-5     Document Type: Article

References (52)

1. Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659-797
2. Zimmermann H (1999) Two novel families of ectonucleotidases: Molecular structures, catalytic properties and a search for function. Trends Pharmacol Sci 20:231-236
3. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rötzsche O, Falk K (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 110:1225-1235
4. Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362:299-309
5. Zimmermann H (2006) Ectonucleotidases in the nervous system. Novartis Found Symp 276:113-128
6. Zimmermann H (2001) Ectonucleotidases: Some recent developments and a note on nomenclature. Drug Devt Res 52:44-56
7. Knowles AF, Li C (2006) Molecular cloning and characterization of expressed human ectonucleoside triphosphate diphosphohydrolase 8 (E-NTPDase8) and its soluble extracellular domain. Biochemistry 45:7323-7333
8. Fausther M, Lecka J, Kukulski F, Lévesque SA, Pelletier J, Zimmermann H, Dranoff JA, Sévigny J (2007) Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8. Am J Physiol Gastrointest Liver Physiol 292:G785-G795
9. Mulero JJ, Yeung G, Nelken ST, Ford JE (1999) CD39-L4 is a secreted human apyrase, specific for the hydrolysis of nucleoside diphosphates. J Biol Chem 274:20064-20067
10. Kukulski F, Komoszynski M (2003) Purification and characterization of NTPDase1 (ecto-apyrase) and NTPDase2 (ecto-ATPase) from porcine brain cortex synaptosomes. Eur J Biochem 270:3447-3454
11. Heine P, Braun N, Sevigny J, Robson SC, Servos J, Zimmermann H (2001) The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2. Eur J Biochem 268:364-373
12. Kirley TL, Crawford PA, Smith TM (2006) The structure of the nucleoside triphosphate diphosphydrolases (NTPDases) as revealed by mutagenic and computational modelin analyses. Purinergic Signalling 2:379-389
13. Heine P, Braun N, Heilbronn A, Zimmermann H (1999) Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells. Eur J Biochem 262:102-107
14. Failer BU, Aschrafi A, Schmalzing G, Zimmermann H (2003) Determination of native oligomeric state and substrate specificity of rat NTPDase1 and NTPDase2 after heterologous expression in Xenopus oocytes. Eur J Biochem 270:1802-1809
15. Robson SC, Sévigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: Structure-function relationships and pathophysiological significance. Purinergic Signalling 2:409-430
16. Sévigny J, Sundberg C, Braun N, Guckelberger O, Csizmadia E, Qawi I, Imai M, Zimmermann H, Robson SC (2002) Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 99:801-2809
17. Wink MR, Braganhol E, Tamajusuku ASK, Lenz G, Zerbini LF, Libermann TA, Sévigny J, Battastini AMO, Robson SC (2006) Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience 138:421-432
18. Langer D, Ikehara Y, Takebayashi H, Hawkes R, Zimmermann H (2007) The ectonucleotidases alkaline phosphatase and nucleoside triphosphate diphosphohydrolase 2 are associated with subsets of progenitor cell populations in the mouse embryonic, postnatal and adult neurogenic zones. Neuroscience 150:863-879
19. Knowles AF, Chiang W-C (2003) Enzymatic and transcriptional regulation of human ecto-ATPase/E-NTPDase 2. Arch Biochem Biophys 418:217-227
20. Buffon A, Ribeiro VB, Wink MR, Casali EA, Sarkis JJ (2007) Nucleotide metabolizing ecto-enzymes in Walker 256 tumor cells: Molecular identification, kinetic characterization and biochemical properties. Life Sci 80:950-958
21. Belcher SM, Zsarnovszky A, Crawford PA, Hemani H, Spurling L, Kirley TL (2006) Immunolocalization of ecto-nucleoside triphosphate for modulation of multiple homeostatic systems including feeding and sleep-wake behaviours. Neuroscience 137:1331-1346
22. Vlajkovic SM, Vinayagamoorthy A, Thorne PR, Robson SC, Wang CJ, Housley GD (2006) Noise-induced up-regulation of NTPDase3 expression in the rat cochlea: Implications for auditory transmission and cochlear protection. Brain Res 1104:55-63
23. Gendron FP, Benrezzak O, Krugh BW, Kong Q, Weisman GA, Beaudoin AR (2002) Purine signaling and potential new therapeutic approach: Possible outcomes of NTPDase inhibition. Curr Drug Targets 3:229-245
24. Kennedy C, Westfall TD, Sneddon P (1996) Modulation of purinergic neurotransmission by ecto-ATPase. Semin Neurosci 8:195-199
25. Dowd FJ, Li LS, Zeng W (1999) Inhibition of rat parotid ecto-ATPase activity. Arch Oral Biol 44:1055-1062
26. Drakulich DA, Spellmon C, Hexum TD (2004) Effect of the ecto-ATPase inhibitor, ARL 67156, on the bovine chromaffin cell response to ATP. Eur J Pharmacol 485:137-140
27. Iqbal J, Vollmayer P, Braun N, Zimmermann H, Müller CE (2005) A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction. Purinergic Signalling 1:349-358
28. Lévesque SA, Lavoie EG, Lecka J, Bigonnesse F, Sévigny J (2007) Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br J Pharmacol 152:141-150
29. Gendron FP, Halbfinger E, Fischer B, Duval M, D'Orléans-Juste P, Beaudoin AR (2000) Novel inhibitors of nucleoside triphosphate diphosphohydrolases: Chemical synthesis and biochemical and pharmacological characterizations. J Med Chem 43:2239-2247
30. Brunschweiger A, Iqbal J, Umbach F, Scheiff AB, Munkonda MN, Sévigny J, Knowles AF, Müller CE (2008) Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: Nucleotide mimetics derived from uridine-5′-carboxamide. J Med Chem, in press
31. Demenis MA, Furriel RP, Leone FA (2003) Characterization of an ectonucleoside triphosphate diphosphohydrolase 1 activity in alkaline phosphatase-depleted rat osseous membranes: Possible functional involvement in the calcification process. Biochem Biophys Acta 1646:216-225
32. Crack BE, Beukers MW, McKechnie KC, Ijzerman AP, Leff P (1994) Pharmacological analysis of ecto-ATPase inhibition: Evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligands. Br J Pharmacol 113:1432-1438
33. Bültmann R, Wittenburg H, Pause B, Kurz G, Nickel P, Starke K (1996) P2-purinoceptor antagonists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin. Naunyn Schmiedebergs Arch Pharmacol 354:498-504
34. Wittenburg H, Bültmann R, Pause B, Ganter C, Kurz G, Starke K (1996) P2-purinoceptor antagonists: II. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue. Naunyn Schmiedebergs Arch Pharmacol 354:491-497
35. Stout JG, Kirley TL (1995) Inhibition of purified chicken gizzard smooth muscle ecto-ATPase by P2 purinoceptor antagonists. Biochem Mol Biol Int 36:927-934
36. Bültmann R, Starke K (1995) Reactive red 2: A P2y-selective purinoceptor antagonist and an inhibitor of ecto-nucleotidase. Naunyn Schmiedebergs Arch Pharmacol 352:477-482
37. Tuluc F, Bültmann R, Glänzel M, Frahm AW, Starke K (1998) P2-receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2. Naunyn Schmiedebergs Arch Pharmacol 357:111-120
38. Hoffmann C, Heine P, Pradel G, Kim YC, Jacobson KA, Zimmermann H (2000) Inhibition of ecto-apyrase and ecto-ATPase by pyridoxal phosphate-related compounds. Drug Dev Res 51:153-158
39. Chen BC, Lee CM, Lin WW (1996) Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages. Br J Pharmacol 119:1628-1634
40. Müller CE, Iqbal J, Baqi Y, Zimmermann H, Röllich A, Stephan H (2006) Polyoxometalates - a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorg Med Chem Lett 16:5943-5947
41. Köhler C, Eckle T, Faigle M, Grenz A, Mittelbronn M, Laucher S, Hart ML, Robson SC, Müller CE, Eltzschig HK (2007) CD39/ ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116:1784-1794
42. Grenz A, Zhang H, Hermes M, Eckle T, Klingel K, Huang DY, Müller CE, Robson SC, Osswald H, Eltzschig HK (2007) Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J 21:2863-2873
43. Coppi E, Pugliese AM, Stephan H, Müller CE, Pedata F (2007) Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices. Purinergic Signalling 3:203-219
44. Munkonda MN, Kauffenstein G, Kukulski F, Lévesque SA, Legendre C, Pelletier J, Lavoie EG, Lecka J, Sévigny J (2007) Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists. Biochem Pharmacol 74:1524-1534
45. 2 receptor antagonists. Bioorg Med Chem Lett 18:223-227
46. Baqi Y, Müller CE (2007) Rapid and efficient microwave-assisted copper(0)-catalyzed Ullmann coupling reaction. Org Lett 9:1271-1274
47. Harris RM, Mariott GJ, Smith JC (1936) The effect of alkyl groups on the properties of anthraquinone and fluorescein dyes. J Chem Soc 1838-1842. DOI 10.1039/JR9360001838
48. Glänzel M, Bültmann R, Starke K, Frahm AW (2003) Members of the acid blue 129 family as potent and selective P2Y-receptor antagonists. Drug Dev Res 59:63-71
49. Bessubetz MK, Rozina VS (1948) Acidic derivatives of anthraquinone. I. Influence of substituents in the phenylamine radical of anthraquinone derivatives on their properties. Zh Prikl Khim 21:1152-1161
50. I.G. Farbenindustrie AG (1933) Anthraquinone derivatives. French Patent FR 751236 19330829
51. Kegel B, Braun N, Heine P, Maliszewski CR, Zimmermann H (1997) An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacology 36:1189-1200
52. Vorhoff T, Zimmermann H, Pelletier J, Sévigny J, Braun N (2005) Cloning and characterization of the ecto-nucleotidase NTPDase3 from rat brain: Predicted secondary structure and relation to other members of the E-NTPDase family and actin. Purinergic Signalling 1:259-270